Pierluigi Paggiaro

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert, Joseph K. Han, Martin Desrosiers et al. · The Lancet · 2019 · 1.5K citations

Medicine, Immunology, Otolaryngology +10

Tiotropium in Asthma Poorly Controlled with Standard Combination Therapy

Huib A.M. Kerstjens, Michael Engel, Ronald Dahl et al. · New England Journal of Medicine · 2012 · 661 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +16

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

Nicola A. Hanania, Phillip E. Korenblat, Kenneth R. Chapman et al. · The Lancet Respiratory Medicine · 2016 · 466 citations

Medicine, Internal Medicine, Pharmacology +10

Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study

Dirkje S. Postma, Christopher E. Brightling, S. Baldi et al. · The Lancet Respiratory Medicine · 2019 · 386 citations · Full text

Medicine, Immunology, Internal Medicine +16

Rescue Use of Beclomethasone and Albuterol in a Single Inhaler for Mild Asthma

Alberto Papi, Giorgio Walter Canonica, Piero Maestrelli et al. · New England Journal of Medicine · 2007 · 368 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17